Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by StevenBirchon Oct 22, 2021 5:12pm
273 Views
Post# 34039258

RE:RE:I Wonder

RE:RE:I WonderI might be a cockeyed optimist but I just don't see how they have dropped the ball. 

In Phase I they had a small problem with screening, for UUTUC, and fixed it. Phase I was stopped early on good results. In Phase II they had the dosing problem and by all accounts fixed that. We wait on the data which is out of their control, they can't speed that up.

So is their 'ineptness' that they don't have updates more regularly? I'm sorry but news releases have nothing to do with the trial or their research. The topic of financing comes up from time to time, do they have enough or will there be another PP or even worse a reverse split but we want them to waste money on a better IR dept. I don't think you can have it both ways.

Look I know people are anxious, some frustrated or even angry at the pace, but the only thing that matters is the data. To think they are intentionally dragging their feet or incompetent is just wrong in my opinion. 
<< Previous
Bullboard Posts
Next >>